Loading…
DIA Europe 2019 has ended
View analytic
Thursday, February 7 • 14:00 - 15:00
#DMD10: Raising Europe’s Voice in Globalising Regulatory Science

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Session

In this session, we aim to take the long view of regulatory science and innovation in establishing the value of medicines and medical treatments, exploring the heritage of European contributions to this scholarship and practice. However, this is undertaken only in the service of the principal goal of this session: to map out the role that Europe could - and should - play in the global evolution of regulation.

Chair

Virginia Lee Acha, PhD, MSc

Speaker

Panel Discussion
Dimitrios Athanasiou, MBA

Panel Discussion
Marieke De Bruin, PharmD, PhD

Panel Discussion
Sini Eskola, MPharm, MSc

Panel Discussion
Ian Hudson

Panel Discussion
Anthony Humphreys, MPharm



Speakers
avatar for Virginia Acha

Virginia Acha

Executive Director, Global Regulatory Policy, MSD
Virginia (Ginny) has worked in industry and academia throughout her career, combining interests in science policy research and innovation performance within and across organizations. She recently joined MSD to lead regulatory policy efforts for innovation that will lead to better... Read More →
avatar for Dimitrios Athanasiou

Dimitrios Athanasiou

Patient Advocate, WORLD DUCHENNE ORGANIZATION (WDO) , MDA HELLAS
Dimitrios Athanasiou is a PDCO member representing EURORDIS. He holds a BA and an MBA in Financial Management He attended Eurordis Summer School and European Patient Academy (EUPATI) acquiring basic biotech and regulatory knowledge. As a full time patient advocate in DMD, he is a... Read More →
avatar for Marieke De Bruin

Marieke De Bruin

Director, Copenhagen Centre for Regulatory Science, Copenhagen University
Marieke De Bruin, PhD was trained as a pharmacist and epidemiologist. Her drug regulatory science research has focused on pharmacoepidemiology in the drug regulatory setting and pharmacovigilance. The main clinical areas are cardiovascular diseases and cancer. As of August 2016, she... Read More →
avatar for Sini Eskola

Sini Eskola

Director Regulatory Affairs, European Federation of Pharmaceutical Industries and Associations (EFPIA)
Sini is working as Regulatory, Drug Development and Manufacturing Director at EFPIA since 2014. She leads regulatory policy and advocacy activities on clinical trials and transparency, pharmacovigilance, regulatory information technology and environmental sustainability aspects. She... Read More →
avatar for Ian Hudson

Ian Hudson

Chief Executive, Medicines and Healthcare products Regulatory Agency (MHRA)
Dr Ian Hudson became Chief Executive of the MHRA in September 2013. He is a physician who practiced as a paediatrician prior to working in the pharmaceutical industry in clinical research and development. In 2001 he joined the former Medicines Control Agency as its Licencing Division... Read More →
avatar for Anthony Humphreys

Anthony Humphreys

Head of Scientific Committees Regulatory Science Strategy, European Medicines Agency, European Union
He is the Head of Scientific Committees Regulatory Science Strategy Division (SciRS). He is responsible for providing leadership in the Agency in the areas of Scientific Committees Coordination and Regulatory Science Strategy in support of delivering the EMRN 2020 Strategy. He chairs... Read More →


Thursday February 7, 2019 14:00 - 15:00
E2 Austria Center Vienna Bruno-Kreisky-Platz 1 1220 Vienna Austria
  • Featured Topics Regulatory Science
  • Tags Session